Abbott Reports Results of Minimally Invasive Device in TRILUMINATE Study for Tricuspid Heart Valve Leaks

 Abbott Reports Results of Minimally Invasive Device in TRILUMINATE Study for Tricuspid Heart Valve Leaks

Abbott Reports Results of Minimally Invasive Device in TRILUMINATE Study for Tricuspid Heart Valve Leaks

Shots:

  • The TRILUMINATE study results involve assessing transcatheter tricuspid valve repair system in 85 patients with symptomatic moderate or greater tricuspid regurgitation across 21 sites including the US and Europe for 30days, presented at EuroPCR
  • The TRILUMINATE study results: reduction in tricuspid regurgitation (86.6%); improvement in KCCQ score (53.05 to 67.25), the study follows MitraClip, clip-based technology intended to treat leaky mitral valves
  • Abbott’s transcatheter tricuspid valve repair is a device intended to treat tricuspid regurgitation caused by a leaky tricuspid heart valve

Click here to read full press release/ article | Ref: Abbott | Image: The New York Times

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post